Literature DB >> 7959678

Multiple endocrine neoplasia type 1 (MEN1) in two Asian families.

B T Teh1, S I Hii, R David, V Parameswaran, S Grimmond, M K Walters, T T Tan, D J Nancarrow, S P Chan, J Mennon.   

Abstract

Multiple endocrine neoplasia type 1 (MEN1), an autosomal dominant disease characterized by neoplasia of the parathyroid glands, anterior pituitary and endocrine pancreas, is rarely reported in Asian populations. The MEN1 gene, mapped to chromosome 11q13 but yet to be cloned, has been found to be homogeneous in Caucasian populations through linkage analysis. Here, two previously unreported Asian kindreds with MEN1 are described; linkage analysis using microsatellite polymorphic markers in the MEN1 region was carried out. The first kindred, of Mongolian-Chinese origin, is a multigeneration family with over 150 living members, eight of whom are affected to date. The second kindred is of Chinese origin consisting of four affected members. Linkage to chromosome 11q13 was confirmed in both kindreds, supporting evidence for genetic homogeneity. A recombination in the larger kindred localizes the gene distal to marker D11S956, consistent with its placement from previous studies. We also show that it is feasible to use these markers for predictive testing, as four gene carriers were detected in 13 family members with unknown disease status in the first kindred.

Entities:  

Mesh:

Year:  1994        PMID: 7959678     DOI: 10.1007/BF00211009

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  20 in total

1.  A minisatellite and a microsatellite polymorphism within 1.5 kb at the human muscle glycogen phosphorylase (PYGM) locus can be amplified by PCR and have combined informativeness of PIC 0.95.

Authors:  H Iwasaki; P W Stewart; W G Dilley; M S Holt; T D Steinbrueck; S A Wells; H Donis-Keller
Journal:  Genomics       Date:  1992-05       Impact factor: 5.736

2.  A second-generation linkage map of the human genome.

Authors:  J Weissenbach; G Gyapay; C Dib; A Vignal; J Morissette; P Millasseau; G Vaysseix; M Lathrop
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

3.  The natural history of multiple endocrine neoplasia type 1. Highly uncommon or highly unrecognized?

Authors:  J J Shepherd
Journal:  Arch Surg       Date:  1991-08

4.  Dinucleotide (CT)n (CA)n repeat polymorphism for D11S787 on chromosome 11q13.4.

Authors:  L D Overbeck; M D Weston; W J Kimberling; G A Evans
Journal:  Hum Mol Genet       Date:  1993-05       Impact factor: 6.150

5.  Evidence of genetic heterogeneity in the long QT syndrome.

Authors:  J Benhorin; Y M Kalman; A Medina; J Towbin; N Rave-Harel; T D Dyer; J Blangero; J W MacCluer; B S Kerem
Journal:  Science       Date:  1993-06-25       Impact factor: 47.728

6.  Genetic studies of thymic carcinoids in multiple endocrine neoplasia type 1.

Authors:  B T Teh; N K Hayward; M K Walters; J J Shepherd; S Wilkinson; M Nordenskjold; C Larsson
Journal:  J Med Genet       Date:  1994-03       Impact factor: 6.318

7.  [Linkage analysis in a Japanese long QT syndrome family].

Authors:  K Akimoto; R Matsuoka; H Kasanuki; A Takao; K Monma; K Hayakawa; S Hosoda
Journal:  Kokyu To Junkan       Date:  1993-05

8.  Cause of death in multiple endocrine neoplasia type 1.

Authors:  S Wilkinson; B T Teh; K R Davey; J P McArdle; M Young; J J Shepherd
Journal:  Arch Surg       Date:  1993-06

9.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

10.  Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms.

Authors:  C Larsson; J Shepherd; Y Nakamura; C Blomberg; G Weber; B Werelius; N Hayward; B Teh; T Tokino; B Seizinger
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

View more
  5 in total

1.  Improved carrier testing for multiple endocrine neoplasia, type 1, using new microsatellite-type DNA markers.

Authors:  S Kytölä; J Leisti; R Winqvist; P Salmela
Journal:  Hum Genet       Date:  1995-10       Impact factor: 4.132

2.  MEN1 935-1G>C splicing mutation in an Indian patient with multiple endocrine neoplasia type 1.

Authors:  Rani Raghavan; Sudeep Shah; Altaf A Kondkar; Alpa J Dherai; Devendra Desai; Phulrenu Chauhan; Murad Lala; Tester F Ashavaid
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

3.  Pancreatic Neuroendocrine Carcinoma Metastatic to the Breast as Part of the Multiple Endocrine Neoplasia Type 1 Syndrome.

Authors:  Isabelle Treilleux; Gilles Freyer; Eric Tabone; Catherine Chassagne-Clement; Alain Bremond; Christiane Bailly
Journal:  Endocr Pathol       Date:  1997       Impact factor: 3.943

4.  Genetic screening in hereditary multiple endocrine neoplasia type 1: absence of a founder effect among Japanese families.

Authors:  A Sakurai; M Katai; Y Itakura; K Nakajima; K Baba; K Hashizume
Journal:  Jpn J Cancer Res       Date:  1996-09

Review 5.  Cystatin C, COVID-19 severity and mortality: a systematic review and meta-analysis.

Authors:  Angelo Zinellu; Arduino A Mangoni
Journal:  J Nephrol       Date:  2021-08-14       Impact factor: 3.902

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.